家族性地中海热

Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford). 2004;43:410-415.

• 全文
• 摘要

Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659-664.

• 摘要

Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev. 2012;12:31-37.

• 摘要

Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879-1885.

• 摘要

Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015;74:635-641.

• 摘要

Hentgen V, Grateau G, Kone-Paut I, et al. Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum. 2013;43:387-391.

• 摘要

Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119:e474-e483.

• 摘要

Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001-1005.

• 摘要

Terkeltaub RA, Furst DE, Digiacinto JL, et al. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63:2226-2237.

• 全文
• 摘要

1.  Siegal S. Benign paroxysmal peritonitis. Gastroenterology. 1949;12:234-247.

• 摘要

2.  Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford). 2004;43:410-415.

• 全文
• 摘要

3.  Zaks N, Shinar Y, Padeh S, et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J. 2003;5:585-588.

• 全文
• 摘要

4.  Tunca M, Akar S, Onen F, et al; Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1-11.

• 摘要

5.  Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227-253.

• 摘要

6.  Saatci U, Ozen S, Ozdemir S, et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr. 1997;156:619-623.

• 摘要

7.  Blum A, Gafni J, Sohar E, et al. Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF): further evidence of its genetic nature. Ann Intern Med. 1962;57:795-799.

• 摘要

8.  Balci B, Tinaztepe K, Yilmaz E, et al. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transplant. 2002;17:1921-1923.

• 全文
• 摘要

9.  Melikoğlu M, Ozdoğan H, Korkmaz C, et al. A survey of phenotype II in familial Mediterranean fever. Ann Rheum Dis. 2000;59:910-913.

• 全文
• 摘要

10.  Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659-664.

• 摘要

11.  Gershoni-Baruch R, Brik R, Shinawi M, et al. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet. 2002;10:145-149.

• 全文
• 摘要

12.  Tunca M, Ozdogan H. Molecular and genetic characteristics of hereditary autoinflammatory diseases. Curr Drug Targets Inflamm Allergy. 2005;4:77-80.

• 摘要

13.  Tchernitchko D, Moutereau S, Legendre M, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum. 2005;52:3603-3605.

• 全文
• 摘要

14.  Majeed HA, Rawashdeh M, el-Shanti H, et al. Familial Mediterranean fever in children: the expanded clinical profile. QJM. 1999;92:309-318.

• 全文
• 摘要

15.  Gershoni-Baruch R, Brik R, Lidar M, et al. Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol. 2003;30:308-312.

• 摘要

16.  The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:787-807.

• 摘要

17.  French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25-31.

• 摘要

18.  Gershoni-Baruch R, Shinawi M, Leah K, et al. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet. 2001;9:634-637.

• 全文
• 摘要

19.  Brik R, Litmanovich D, Berkowitz D, et al. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr. 2001;138:759-762.

• 摘要

20.  Aganna E, Hawkins PN, Ozen S, et al. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun. 2004;5:289-293.

• 全文
• 摘要

21.  Akar N, Akar E, Yalçinkaya F. E148Q of the MEFV gene causes amyloidosis in familial Mediterranean fever patients. Pediatrics. 2001;108:215.

• 摘要

22.  Topaloglu R, Ozaltin F, Yilmaz E, et al. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis. 2005;64:750-752.

• 全文
• 摘要

23.  Tchernitchko DO, Gérard-Blanluet M, Legendre M, et al. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis. 2006;65:1154-1157.

• 摘要

24.  Tchernitchko D, Legendre M, Cazeneuve C, et al. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat. 2003;22:339-340.

• 全文
• 摘要

25.  Marek-Yagel D, Bar-Joseph I, Pras E, et al. Is E148Q a benign polymorphism or a disease-causing mutation? J Rheumatol. 2009;36:2372.

• 全文
• 摘要

26.  Hershko AY, Ben-Chetrit E. The MEFV E148Q allele: a deleterious mutation or harmless variation? Clin Exp Rheumatol. 2006;24(suppl 42):S51-S52.

• 摘要

27.  Ben-Chetrit E, Lerer I, Malamud E, et al. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat. 2000;15:385-386.

• 全文
• 摘要

28.  Kastner DL. Familial Mediterranean fever: the genetics of inflammation. Hosp Pract (Minneap). 2006;15:131-134.

• 摘要

29.  Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93:217-221.

• 全文
• 摘要

30.  Aldea A, Campistol JM, Arostegui JI, et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? Am J Med Genet A. 2004;124A:67-73.

• 全文
• 摘要

31.  Stoffels M, Szperl A, Simon A, et al. MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Ann Rheum Dis. 2014;73:455-461.

• 摘要

32.  Kone-Paut I, Hentgen V, Guillaume-Czitrom S, et al. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford). 2009;48:840-842.

• 全文
• 摘要

33.  Marek-Yagel D, Berkun Y, Padeh S, et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009;60:1862-1866.

• 全文
• 摘要

34.  Moradian MM, Sarkisian T, Ajrapetyan H, et al. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet. 2010;55:389-393.

• 摘要

35.  Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev. 2012;12:31-37.

• 摘要

36.  Touitou I. Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature. J Med Genet. 2013;50:349-359.

• 全文
• 摘要

37.  Federici S, Calcagno G, Finetti M, et al. Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. Ann Rheum Dis. 2012;71:1961-1965.

• 摘要

38.  Karadag O, Tufan A, Yazisiz V, et al. The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int. 2013;33:893-897.

• 摘要

39.  Papin S, Cuenin S, Agostini L, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007;14:1457-1466.

• 全文
• 摘要

40.  Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol. 2009;146:467-478.

• 全文
• 摘要

41.  Simon A, van der Meer JW. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007;292:R86-R98.

• 全文
• 摘要

42.  Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001;345:1748-1757.

• 摘要

43.  Ben-Zvi I, Danilesko I, Yahalom G, et al. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever. Isr Med Assoc J. 2012;14:221-224.

• 全文
• 摘要

44.  Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets Inflamm Allergy. 2005;4:113-116.

• 摘要

45.  Kone Paut I, Dubuc M, Sportouch J, et al. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford). 2000;39:1275-1279.

• 摘要

46.  Dewalle M, Domingo C, Rozenbaum M, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever. Eur J Hum Genet. 1998;6:95-97.

• 全文
• 摘要

47.  Grateau G. The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol. 2000;12:61-64.

• 摘要

48.  Sidi G, Shinar Y, Livneh A, et al. Protracted febrile myalgia of familial Mediterranean fever: mutation analysis and clinical correlations. Scand J Rheumatol. 2000;29:174-176.

• 摘要

49.  Grateau G, Pêcheux C, Cazeneuve C, et al. Clinical versus genetic diagnosis of familial Mediterranean fever. QJM. 2000;93:223-229.

• 全文
• 摘要

50.  Ozen S, Bakkaloglu A, Yilmaz E, et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol. 2003;30:2014-2018.

• 摘要

51.  Lachmann HJ, Sengül B, Yavuzşen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-750.

• 全文
• 摘要

52.  Ozen S. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum. 2009;60:1575-1577.

• 全文
• 摘要

53.  Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56:1706-1712.

• 全文
• 摘要

54.  Simon A, van der Meer JW, Vesely R, et al. Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford). 2006;45:269-273.

• 全文
• 摘要

55.  Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879-1885.

• 摘要

56.  Padeh S, Livneh A, Pras E, et al. Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol. 2010;37:865-869.

• 摘要

57.  Berkun Y, Padeh S, Reichman B, et al. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum. 2007;37:182-188.

• 摘要

58.  Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med. 1972;287:1302.

• 摘要

59.  Sugiura T, Kawaguchi Y, Fujikawa S, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol. 2008;18:57-59.

• 摘要

60.  Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015;74:635-641.

• 摘要

61.  Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:477-498.

• 摘要

62.  Brik R, Shinawi M, Kasinetz L, et al. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416-1419.

• 全文
• 摘要

63.  Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Semin Arthitis Rheum. 1996;26:612-627.

• 摘要

64.  Rimar D, Rosner I, Rozenbaum M, et al. Familial Mediterranean fever: an association with non-alcoholic fatty liver disease. Clin Rheumatol. 2011;30:987-991.

• 摘要

65.  Tweezer-Zaks N, Doron-Libner A, Weiss P, et al. Familial Mediterranean fever and cryptogenic cirrhosis. Medicine (Baltimore). 2007;86:355-362.

• 摘要

66.  Barzilai A, Langevitz P, Goldberg I, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol. 2000;42:791-795.

• 摘要

67.  Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience. Best Pract Res Clin Rheumatol. 2012;26:119-133.

• 摘要

68.  Lossos A, Eliashiv S, Ben-Chetrit E, et al. Optic neuritis associated with familial Mediterranean fever. J Clin Neuroophthalmol. 1993;13:141-143.

• 摘要

69.  Dabestani A, Noble LM, Child JS, et al. Pericardial disease in familial Mediterranean fever: an echocardiographic study. Chest. 1982;5:592-595.

• 摘要

70.  Kees S, Langevitz P, Zemer D, et al. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643-647.

• 摘要

71.  Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr. 2010;99:178-184.

• 摘要

72.  Thomas KT, Feder HM Jr, Lawton AR, et al. Periodic fever syndrome in children. J Pediatr. 1999;135:15-21.

• 摘要

73.  Gattorno M, Sormani MP, D'Osualdo A, et al. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum. 2008;58:1823-1832.

• 全文
• 摘要

74.  Chitkara P, Stojanov S, Kastner DL. The hereditary autoinflammatory syndromes. Pediatr Infect Dis J. 2007;26:353-354.

• 摘要

75.  Frenkel J, Kuis W. Overt and occult rheumatic diseases: the child with chronic fever. Best Pract Res Clin Rheumatol. 2002;16:443-469.

• 摘要

76.  Farasat S, Aksentijevich I, Toro J. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol. 2008;144:392-402.

• 摘要

77.  Masson C, Simon V, Hoppe E, et al. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine. 2004;71:284-290.

• 摘要

78.  Williamson LM, Hull D, Mehta R, et al. Familial Hibernian fever. Q J Med. 1982;51:469-480.

• 摘要

79.  Samuels J, Ozen S. Familial Mediterranean fever and other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006;18:108-117.

• 摘要

80.  Kastner D. Hereditary periodic fever syndromes. Hematology Am Soc Hematol Educ Program. 2005;74-81.

• 全文
• 摘要

81.  Lidar M, Scherrmann JM, Shinar Y, et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum. 2004;33:273-282.

• 摘要

82.  Livneh A, Zemer D, Langevitz P, et al. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum. 1994;37:1804-1811.

• 摘要

83.  Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum. 2009;38:411-419.

• 摘要

84.  Majeed HA, Al-Qudah AK, Qubain H, et al. The clinical patterns of myalgia in children with familial Mediterranean fever. Semin Arthritis Rheum. 2000;30:138-143.

• 摘要

85.  Meinzer U, Quartier P, Alexandra JF, et al. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011;41:265-271.

• 摘要

86.  Hashkes PJ, Spalding SJ, Giannini EH, et al. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med. 2012;157:533-541.

• 摘要

87.  Ozen S, Bilginer Y, Aktay Ayaz N, et al. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. J Rheumatol. 2011;38:516-518.

• 摘要

88.  Ter Haar N, Lachmann H, Özen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013;72:678-685.

• 摘要

89.  Hentgen V, Grateau G, Kone-Paut I, et al. Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum. 2013;43:387-391.

• 摘要

90.  Bilgen SA, Kilic L, Akdogan A, et al. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment. J Clin Rheumatol. 2011;17:358-362.

• 摘要

91.  Ben-Chetrit E, Aamar S. About colchicine compliance, resistance and virulence. Clin Exp Rheumatol. 2009;27(suppl):S1-S3.

• 摘要

92.  Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum. 1991;20:241-246.

• 摘要

93.  Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119:e474-e483.

• 摘要

94.  Tunca M, Akar S, Soyturk M, et al. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clin Exp Rheumatol. 2004;22(suppl):S37-S40.

• 摘要

95.  Kataoka H, Kumagai H, Hanai H. Treating familial Mediterranean fever with prazosin hydrochloride. Ann Intern Med. 1998;129:424.

• 摘要

96.  Sayarlioglu M, Sayarlioglu H, Ozen S, et al. Colchicine-induced myopathy in a teenager with familial Mediterranean fever. Ann Pharmacother. 2003;37:1821-1824.

• 摘要

97.  Milledge J, Shaw PJ, Mansour A, et al. Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood. 2002;100:774-777.

• 全文
• 摘要

98.  Dinarello CA, Wolff SM, Goldfinger SE, et al. Colchicine therapy for familial mediterranean fever: a double-blind trial. N Engl J Med. 1974;291:934-937.

• 摘要

99.  Ben-Chetrit E, Berkun Y, Ben-Chetrit E, et al. The outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicine. Semin Arthritis Rheum. 2004;34:549-552.

• 摘要

100.  Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001-1005.

• 摘要

101.  Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72.

• 摘要

102.  Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003;62:916-919.

• 摘要

103.  Ben-Chetrit E, Scherrmann JM, Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum. 1996;39:1213-1217.

• 摘要

104.  Ben-Chetrit E, Ben-Chetrit A, Berkun Y, et al. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res (Hoboken). 2010;62:143-148.

• 全文
• 摘要

105.  Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int. 2011;31:1263-1274.

• 摘要

106.  Ozçakar ZB, Yalçınkaya F. Vascular comorbidities in familial Mediterranean fever. Rheumatol Int. 2011;31:1275-1281.

• 摘要

107.  Espinosa G, Arostegui JI, Plaza S, et al. Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol. 2005;23(suppl):S64-S66.

• 摘要

108.  Imirzalioglu N, Dursun A, Tastan B, et al. MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol. 2005;34:56-58.

• 摘要

109.  Schwartz T, Langevitz P, Zemer D, et al. Behçet's disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-295.

• 摘要

110.  Livneh A, Aksentijevich I, Langevitz P, et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet. 2001;9:191-196.

• 全文
• 摘要

111.  Korkmaz C, Kaşifoğlu T. Changes in the liver function tests during the attacks of familial Mediterranean fever. Rheumatol Int. 2007;27:395-398.

• 摘要

112.  Terkeltaub RA, Furst DE, Digiacinto JL, et al. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63:2226-2237.

• 全文
• 摘要

113.  Finkelstein Y, Aks SE, Hutson JR, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48:407-414.

• 摘要